Company intelligence / Profile preview
Kangrentang
- Ownership
- Private
- Employees
- ~2000
- Development stage
- Other
Overview
Beijing Kangrentang Pharmaceutical is a prominent Chinese pharmaceutical company specializing in the modernization of Traditional Chinese Medicine (TCM). As a key subsidiary of Tianjin Chase Sun Pharmaceutical, it is a pioneer and market leader in the development and production of TCM dispensing granules. The company utilizes advanced extraction, separation, and concentration technologies to transform traditional herbal decoctions into standardized, easy-to-use granules. Its products are widely utilized in hospitals across China, offering a consistent and scientific approach to traditional therapies. Kangrentang maintains extensive GMP-certified manufacturing facilities and focuses on the digital traceability of herbal medicine from cultivation to clinical use.
- Therapeutic areas
- ImmunologyWomen's HealthCardiovascularInfectious DiseasesGastroenterology
- Modalities
- Traditional Chinese MedicineBotanical extractSmall molecule
- Industry
- Biotech
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →Partnerships
Beyond the preview
Go deeper on Kangrentang.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Kangrentang.